IGLV3-21R110突变对未经治疗的慢性淋巴细胞白血病患者具有预后价值。 - Suppr

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.

作者信息

Syrykh Charlotte, Pons-Brun Berta, Russiñol Núria, Playa-Albinyana Heribert, Baumann Tycho, Duran-Ferrer Martí, Kulis Marta, Carbó-Meix Anna, Mozas Pablo, Alcoceba Miguel, González Marcos, Navarro-Bailón Almudena, Colado Enrique, Payer Ángel R, Aymerich Marta, Terol María J, Lu Junyan, Knisbacher Binyamin A, Hahn Cynthia K, Ruiz-Gaspà Sílvia, Enjuanes Anna, Wu Catherine J, Getz Gad, Zenz Thorsten, López-Guillermo Armando, Martín-Subero José I, Colomer Dolors, Delgado Julio, Campo Elías, Nadeu Ferran

机构信息

Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Department of Pathology, Institut Universitaire du Cancer, CHU de Toulouse, Toulouse, France.

出版信息

Blood Adv. 2023 Dec 12;7(23):7384-7391. doi: 10.1182/bloodadvances.2023010132.

DOI:10.1182/bloodadvances.2023010132

PMID:37505099

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10726246/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe4c/10726246/3e817164d4f5/BLOODA_ADV-2023-010132-gr1ad.jpg

相似文献

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.IGLV3-21R110突变对未经治疗的慢性淋巴细胞白血病患者具有预后价值。

Blood Adv. 2023 Dec 12;7(23):7384-7391. doi: 10.1182/bloodadvances.2023010132.

Time to include IGLV3-21R110 status in CLL prognostication?是时候将IGLV3-21R110状态纳入慢性淋巴细胞白血病的预后评估了吗？

Blood Adv. 2023 Dec 12;7(23):7382-7383. doi: 10.1182/bloodadvances.2023011243.

IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.IGLV3-21R110 鉴定出具有中间表观遗传学的侵袭性慢性淋巴细胞白血病生物学亚型。

Blood. 2021 May 27;137(21):2935-2946. doi: 10.1182/blood.2020008311.

is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling.是 CLL 的遗传风险因素，通过获得允许自主 BCR 信号转导的单点突变。

Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4320-4327. doi: 10.1073/pnas.1913810117. Epub 2020 Feb 11.

The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.轻链 IgLV3-21 定义了慢性淋巴细胞白血病的一个新的预后不良亚组：一项多中心研究的结果。

Clin Cancer Res. 2018 Oct 15;24(20):5048-5057. doi: 10.1158/1078-0432.CCR-18-0133. Epub 2018 Jun 26.

Use of IGHJ and IGHD gene mutations in analysis of immunoglobulin sequences for the prognosis of chronic lymphocytic leukemia.IGHJ和IGHD基因突变在慢性淋巴细胞白血病免疫球蛋白序列分析中用于预后评估的应用

Leuk Res. 2007 Sep;31(9):1247-52. doi: 10.1016/j.leukres.2006.10.013. Epub 2006 Dec 13.

Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?具有突变型IgVH1-69使用情况的慢性淋巴细胞白血病：一种行为更惰性的独特慢性淋巴细胞白血病亚组？

Leuk Lymphoma. 2008 Apr;49(4):648-9. doi: 10.1080/10428190801959059.

Another step forward in the 20-year history of mutations in chronic lymphocytic leukemia.慢性淋巴细胞白血病突变20年历史中的又一进展。

Haematologica. 2019 Feb;104(2):219-221. doi: 10.3324/haematol.2018.207399.

Chronic lymphocytic leukemia: to transplant or not to transplant... that is the question?慢性淋巴细胞白血病：移植与否……这是个问题？

J Clin Oncol. 2005 Nov 1;23(31):8126-7; author reply 8127. doi: 10.1200/JCO.2005.03.1690.

Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?B细胞慢性淋巴细胞白血病中IgV(H)基因的突变状态与预后：突变百分比还是抗原驱动选择？

Leukemia. 2005 Aug;19(8):1490-2. doi: 10.1038/sj.leu.2403830.

引用本文的文献

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.成熟B细胞肿瘤中疾病特异性的U1剪接体RNA突变

Leukemia. 2025 Jun 30. doi: 10.1038/s41375-025-02667-7.

Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies.慢性淋巴细胞白血病中基因畸变与信号通路相互作用的见解：从发病机制到治疗策略

Biomark Res. 2024 Dec 28;12(1):162. doi: 10.1186/s40364-024-00710-w.

Time to include IGLV3-21R110 status in CLL prognostication?是时候将IGLV3-21R110状态纳入慢性淋巴细胞白血病的预后评估了吗？

Blood Adv. 2023 Dec 12;7(23):7382-7383. doi: 10.1182/bloodadvances.2023011243.

本文引用的文献

Molecular map of chronic lymphocytic leukemia and its impact on outcome.慢性淋巴细胞白血病的分子图谱及其对预后的影响。

Nat Genet. 2022 Nov;54(11):1664-1674. doi: 10.1038/s41588-022-01140-w. Epub 2022 Aug 4.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版：淋巴肿瘤。

Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.成熟淋巴细胞肿瘤国际共识分类：临床咨询委员会报告。

Blood. 2022 Sep 15;140(11):1229-1253. doi: 10.1182/blood.2022015851.

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL.慢性淋巴细胞白血病中的免疫球蛋白基因序列分析：ERIC（慢性淋巴细胞白血病欧洲研究倡议）的 2022 年更新建议。

Leukemia. 2022 Aug;36(8):1961-1968. doi: 10.1038/s41375-022-01604-2. Epub 2022 May 25.

Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21.携带IGLV3-21的慢性淋巴细胞白血病中新型药物的临床生物学特征及治疗疗效

Leukemia. 2022 Jul;36(7):1935-1938. doi: 10.1038/s41375-022-01600-6. Epub 2022 May 18.

Prevalence of IGLV3-21R110 among familial CLL: a retrospective study of 45 cases.家族性慢性淋巴细胞白血病中IGLV3-21R110的患病率：45例回顾性研究

Blood Adv. 2022 Jun 28;6(12):3632-3635. doi: 10.1182/bloodadvances.2021006658.

Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.多组学揭示了慢性淋巴细胞白血病中与mTOR-MYC-氧化磷酸化活性相关的临床相关增殖驱动因素。

Nat Cancer. 2021 Aug;2(8):853-864. doi: 10.1038/s43018-021-00216-6. Epub 2021 Jul 1.

Exploring the pathways to chronic lymphocytic leukemia.探讨慢性淋巴细胞白血病的发病途径。

Blood. 2021 Sep 9;138(10):827-835. doi: 10.1182/blood.2020010029.

Blood. 2021 May 27;137(21):2935-2946. doi: 10.1182/blood.2020008311.

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南

Ann Oncol. 2021 Jan;32(1):23-33. doi: 10.1016/j.annonc.2020.09.019. Epub 2020 Oct 19.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献